Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study by Elena Barbuti, Alessia Castiello, Valeria Pozzilli, Antonio Carotenuto, Ilaria Tomasso, Marcello Moccia, Serena Ruggieri, Giovanna Borriello, Roberta Lanzillo, Vincenzo Brescia Morra, Carlo Pozzilli, Maria Petracca

Get full text

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis by Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola deCandia, Giuseppe Matarese

Get full text